INTRATHECAL BETA-INTERFERON IN MULTIPLE-SCLEROSIS

被引:0
|
作者
MILANESE, C [1 ]
SALMAGGI, A [1 ]
LAMANTIA, L [1 ]
CORRIDORI, F [1 ]
NESPOLO, A [1 ]
机构
[1] IST NEUROL C BESTA,DEPT CLIN INVEST,I-20133 MILAN,ITALY
来源
LANCET | 1988年 / 2卷 / 8610期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:563 / 564
页数:2
相关论文
共 50 条
  • [21] INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS
    METZ, L
    BELL, R
    ZOCHODNE, O
    NEUROLOGY, 1994, 44 (01) : 187 - 188
  • [22] INTRATHECAL INTERFERON AS TREATMENT OF MULTIPLE-SCLEROSIS - A PLANNED MULTICENTER STUDY
    JACOBS, L
    OMALLEY, JA
    FREEMAN, A
    REESE, P
    ARCHIVES OF NEUROLOGY, 1983, 40 (11) : 683 - 686
  • [23] Association between beta-interferon exposure and hospital events in multiple sclerosis
    Evans, Charity
    Zhu, Feng
    Kingwell, Elaine
    Shirani, Afsaneh
    van der Kop, Mia L.
    Petkau, John
    Gustafson, Paul
    Zhao, Yinshan
    Oger, Joel
    Tremlett, Helen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (11) : 1213 - 1222
  • [24] Predicting beta-interferon failure in relapsing-remitting multiple sclerosis
    O'Rourke, K.
    Walsh, C.
    Antonelli, G.
    Hutchinson, M.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (03) : 336 - 342
  • [25] Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns
    O'Rourke, KET
    Hutchinson, M
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (01) : 46 - 50
  • [26] INTRATHECAL CYTARABINE IN MULTIPLE-SCLEROSIS
    GORE, M
    BUCKMAN, R
    STERN, G
    LANCET, 1979, 2 (8135): : 204 - 204
  • [27] INTRATHECAL INTERFERON IN THE TREATMENT OF MULTIPLE-SCLEROSIS - PATIENT FOLLOW-UP
    JACOBS, L
    OMALLEY, JA
    FREEMAN, A
    EKES, R
    REESE, PA
    ARCHIVES OF NEUROLOGY, 1985, 42 (09) : 841 - 847
  • [28] INTRATHECAL DIAMORPHINE AND MULTIPLE-SCLEROSIS
    ALDERSON, JD
    ANAESTHESIA, 1990, 45 (12) : 1084 - 1085
  • [29] FDA OKAYS INTERFERON-BETA FOR MULTIPLE-SCLEROSIS
    THAYER, A
    CHEMICAL & ENGINEERING NEWS, 1993, 71 (31) : 5 - 6
  • [30] INTERFERON IN MULTIPLE-SCLEROSIS
    FARKKILA, M
    IIVANAINEN, M
    CLINICAL NEUROPHARMACOLOGY, 1988, 11 (02) : 120 - 129